Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Phibro Animal Health Corporation Class A

Stage 1 · Basing · week 10

As of Oct 22, 2026, Phibro Animal Health is in Stage 1, the basing phase, now in week 10 (since Aug 17, 2026). It closed at $39.81, 32.7% below its 52-week high and below its 200-day average, which is falling.

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. More about the company

$39.81
+1.43% today
$1.6B · Small cap
Market Neutral — Building

Pro read

Pro

Our read

Basing, not in an uptrend yet

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is PAHC early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2023-08-16 → 2026-10-22
S4 18w
S2 38w
S2 29w
2023-08-162026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S2 5w → S4 18w → S1 11w → S2 38w → S3 9w → S2 5w → S3 2w → S4 5w → S1 4w → S2 29w → S3 4w → S2 13w → S3 5w → S4 9w → S1 10w current
Total tracked: 166 weeks across 15 stage runs.

PAHC among Drug Manufacturers - Specialty & Generic31st of 84 by relative strength

All 84 →
Stocks in Drug Manufacturers - Specialty & Generic ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CPIXStage 2 · wk 2398+6.8%
2ETONStage 2 · wk 3097−10.1%
3ANIKStage 2 · wk 1596+3.5%
4IRWDStage 3 · wk 396−16.4%
5TEVAStage 2 · wk 995+3.1%
6AMRXStage 2 · wk 1995+5.9%
7KNSAStage 2 · wk 7395+6.2%
8AMLXStage 2 · wk 1593−6.6%
…31PAHCStage 1 · wk 1052+16.7%
vs 52W High
-32.7%
$28.31 lo$59.14 hi
32.7% below 52W high, far from high
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 10
1w13w26w
Week 10, base building
How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.
vs 200 DMA
-3.1%
200 DMA: $41.07 · sloping down
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
1.09x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+16.7%
3M
+17.3%
6M
-26.7%
YTD
+7.8%
1Y
-2.8%
Scan Membership
Breakout Watch
Latest: 2025-06-27
7 appearances in last 60 days. First seen: 2020-06-03.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding. Staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-22S1
Wk 10 · Vol 1.09x
2026-10-21S1
Wk 10 · Vol 0.57x
2026-10-20S1
Wk 10 · Vol 0.66x
2026-10-19S1
Wk 9 · Vol 0.79x
2026-10-16S1
Wk 9 · Vol 0.80x
2026-10-15S1
Wk 9 · Vol 0.79x
2026-10-14S1
Wk 9 · Vol 1.23x
2026-10-13S1
Wk 9 · Vol 1.78x
2026-10-12S1
Wk 8 · Vol 0.90x
2026-10-09S1
Wk 8 · Vol 1.03x
2026-10-08S1
Wk 8 · Vol 1.05x
2026-10-07S1
Wk 8 · Vol 0.86x
Moving averages & range
50 DMA
$36.49
200 DMA
$41.07
52W High
$59.14
52W Low
$28.31
5D Low
$38.80
Resistance levels (recent highs)
20d High
$39.81
60d High
$39.92
120d High
$58.07
250d High
$59.14
Next resistance
+0.3%
to 60d High
P/E (TTM)
16.4
Forward 10.3
Earnings Growth (YoY)
+24.6%
Revenue +4.8%
ROE
+29.7%
Profit margin +6.6%
Dividend Yield
1.22%
P/B 4.2

Phibro Animal Health: quick answers

What stage is Phibro Animal Health in?

As of Oct 22, 2026, Phibro Animal Health (PAHC) is in Stage 1, the basing phase. It entered Stage 1 on Aug 17, 2026 and is in week 10. What the four stages mean

Is Phibro Animal Health in an uptrend?

Not yet. Phibro Animal Health is in Stage 1, a base that can come before an uptrend. It trades 3.1% below its 200-day average, which is falling.

How far is Phibro Animal Health from its 52-week high?

Phibro Animal Health closed at $39.81 on Oct 22, 2026, 32.7% below its 52-week high of $59.14. Its 52-week low is $28.31.

How has Phibro Animal Health performed over the past year?

As of Oct 22, 2026, Phibro Animal Health is down 2.8% over the past year and up 7.8% so far in 2026.

Which sector and industry is Phibro Animal Health in?

Phibro Animal Health is in the Drug Manufacturers - Specialty & Generic industry, part of the Health Care sector.

About this companyHealth Care· Drug Manufacturers - Specialty & Generic

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.